Clinical trials in the USA: a comparison with Asia
- At: 2007 FIP Congress in Beijing (China)
- Type: Presentation
- By: JILL, Martin (University of Cincinnati, Cincinnati, United States of America)
The number of drugs and devices entering clincal development is continuing to escalate. While the U.S. has always required a rigorous procedure for new products to reach the market, recent product withdrawals have heightened attention to the clincal trials process and are driving further change. The movement is toward more data to document drug.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.